Company Analysis

Tevogen Bio Holdings Inc. (TVGN)

Nasdaq: TVGN · Biological Products, (No Diagnostic Substances) · Warren, NJ · filing with the SEC since 2021
Grade3.3
◀ Past 2.6● Present 3.1▶ Future 4.0
7 est.

Who runs Tevogen Bio Holdings Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Saadi Ryan H.
Chief Executive Officer. First filing Feb 2024, latest Nov 4, 2026, 2 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
22 people on the record since 2021
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Saadi Ryan H.Chief Executive OfficerFeb 2024Nov 4, 2026none
Desai KirtiChief Financial OfficerFeb 2024Sep 16, 2026none
Flomenberg NealChief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effFeb 2024Mar 17, 20263 · $0.00
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Feike Jeffrey L.directorFeb 2024Sep 15, 2026none
Goh Keow LindirectorFeb 2024Sep 15, 2026none
Patton Curtis L.directorFeb 2024Sep 15, 2026none
Podlogar Susan MdirectorFeb 2024Sep 15, 2026none
Sordillo Victor J.directorFeb 2024Sep 15, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TVGN · research, not advice